The indication approved for Mounjaro (generic name: tirzepatide) in Japan is type 2 diabetes. Using Mounjaro for weight loss or dieting falls outside the approved scope, making it “off-label use”; it is self-pay treatment not covered by Japan’s public health insurance, and you pay the full cost.
Being self-pay treatment is not the same as being illegal. However, Mounjaro is a prescription drug that requires a doctor’s examination and prescription. Avoid buying it without having your health, medical history and other medications checked, and do not increase or decrease the dose on your own.
The short answerBusy? Just read this part
- Using Mounjaro for weight loss is off-label use under self-pay treatment, and you pay the full cost.
- Mounjaro’s approved use is type 2 diabetes. It differs in brand name, approved indications and conditions of use from Zepbound, a treatment for obesity disease that contains the same active ingredient.
- Not being covered by insurance is not the same as being illegal, but a doctor’s examination, explanation and prescription are required.
- Self-pay treatment costs vary by medical institution, so check the total, including not only the drug cost but also the consultation fee, test fees and shipping.
- Personal import is not necessarily illegal in all cases, but quality, efficacy and safety may not have been confirmed in Japan, and reselling or transferring the drug to others is not permitted.
Is Mounjaro self-pay? The answer first
Using Mounjaro for weight loss for dieting or cosmetic purposes is, in principle, self-pay treatment. Because public health insurance cannot be used for self-pay treatment, the patient pays for the consultation, tests, medication, delivery and other costs.
On the other hand, Mounjaro is approved in Japan as a treatment for type 2 diabetes. If you have been diagnosed with type 2 diabetes, a doctor decides it is medically necessary, and the requirements for insurance-covered care are met, it may be prescribed under insurance-covered care. Use for slimming cannot be treated as type 2 diabetes treatment to have insurance apply.
| Item | Treating type 2 diabetes | Weight loss / dieting |
|---|---|---|
| Mounjaro’s approved scope | Approved indication | Off-label use outside the approved scope |
| Type of care | May be insurance-covered care if requirements are met | Self-pay treatment |
| Cost | Copay depending on age, income, etc. | You pay the full cost |
| Who decides | The examining doctor decides based on the diagnosis, health condition and treatment purpose | |
Differences between Mounjaro and Zepbound
Mounjaro and Zepbound are both injectable drugs with the active ingredient tirzepatide, but their approved indications in Japan differ.
Mounjaro:
Treatment for type 2 diabetes
Zepbound:
Treatment for obesity disease meeting certain conditions
It is not accurate to think that “because it has the same ingredient, Mounjaro is also approved for obesity disease.” The statement on the safe and appropriate use of obesity medications posted by the PMDA also distinguishes Mounjaro and Zepbound as separate products. Which one is appropriate for treatment is decided by a doctor based on your diagnosis and health condition.
Is off-label use of Mounjaro illegal?
It is not accurate to call all self-pay prescriptions illegal just because they are not covered by insurance or are off-label use. However, a doctor must examine you and explain the expected effects, how this differs from the uses approved in Japan, side effects, alternative treatments, costs and more before deciding whether treatment is appropriate.
Mounjaro is a prescription-only drug. Sales websites and person-to-person deals on social media that advertise “no consultation,” “no prescription needed” or “anyone can buy” are different from self-pay treatment at a legitimate medical institution. Even with online consultation, you do not purchase automatically after a questionnaire; a doctor examines you in real time and decides whether a prescription is appropriate.
Is all personal import and online purchase illegal? The correct cautions
Personal import of medicines is not uniformly prohibited in all cases. The Ministry of Health, Labour and Welfare explains that personal import may be permitted only for your own use, subject to conditions such as type and quantity. On the other hand, selling or transferring personally imported medicines to others, or importing on behalf of others in bulk, is not permitted.
Personally imported products are not necessarily guaranteed to have the same quality, efficacy and safety as medicines legitimately distributed in Japan. It is also difficult to detect counterfeits, improper temperature control or differences in ingredient amounts just by looking at them. If you want Mounjaro, a self-injected drug, avoid personal import and buying through social media, and see a doctor at a medical institution.
How much does self-pay treatment with Mounjaro cost?
Self-pay prices are set by each medical institution, so they are not uniform nationwide. Check not only the price per pen but also the 4 pens usually used in a month, the consultation fee, test fees, shipping and the terms of subscription delivery.
| Dose | Drug cost for 4 pens | Including standard shipping | Including subscription shipping |
|---|---|---|---|
| 2.5mg | ¥17,600 | ¥19,250 | ¥18,260 |
| 5mg | ¥25,920 | ¥27,570 | ¥26,580 |
| 7.5mg | ¥61,600 | ¥63,250 | ― |
*The Japanese original is authoritative.
Hiro Clinic prices (tax incl., as of August 25, 2026). Calculated by adding the standard shipping fee of ¥1,650 or the subscription shipping fee of ¥660. The shipping fee for Hokkaido and Okinawa is ¥2,200. Additional costs may apply depending on the consultation, additional tests and other factors. Please check the latest pricing page before applying.
How to get started from your first visit, consultation hours and refrigerated delivery are explained in detail in our guide to online consultation for Mounjaro.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Is self-pay treatment with Mounjaro eligible for the medical expense deduction?
Diet costs aimed only at appearance or health promotion are generally not eligible for Japan’s medical expense deduction. The National Tax Agency explains that the cost of medicines needed for treatment or recuperation can be eligible, while medicines for disease prevention or health promotion are not.
If treatment was given for a disease diagnosed by a doctor, such as obesity disease, the treatment may differ depending on the purpose of treatment and what the expenses were for. Rather than deciding uniformly based only on whether it was self-pay, check your receipts and the details of your care and consult the tax office or a tax accountant.
5 points to check for self-pay treatment
Whether a doctor examines you and decides on the prescription:
Make sure it is not a system where medication arrives automatically without a consultation.
Whether off-label use is explained:
You receive an explanation of the uses approved in Japan, expected effects, side effects and alternative treatments.
Whether the monthly total is clear:
Check the drug cost, consultation fee, test fees, shipping and subscription terms.
Whether there is someone to consult about side effects:
Check how to get in touch, reception hours and where to go in an emergency.
Whether legitimate distribution and storage can be confirmed:
Check that the injectable drug is properly temperature-controlled and sent by refrigerated delivery.
Main side effects of Mounjaro and when to seek care
With Mounjaro, digestive symptoms such as nausea, vomiting, diarrhea, constipation, abdominal pain and loss of appetite may occur. If symptoms continue to the point where you cannot keep fluids down, or if you have severe abdominal pain, difficulty breathing, impaired consciousness or similar symptoms, do not wait and see on your own; contact the prescribing medical institution or an emergency medical facility.
Do not change the injection method or dose on your own; follow the PMDA patient medication guide and the prescribing doctor’s instructions. For what to check during long-term use, see also long-term use of Mounjaro and safety monitoring.
About self-pay treatment and off-label use
Frequently asked questions about self-pay treatment with Mounjaro
QCan Mounjaro be used under self-pay treatment?
After a doctor examines you and explains that it is off-label use, its side effects, costs and so on, it may be prescribed as self-pay treatment for weight loss. It is not prescribed for everyone.
QIs prescribing it under self-pay treatment illegal?
It is not accurate to call all self-pay treatment illegal just because it is not covered by insurance or is off-label use. A doctor’s examination, explanation and prescription are prerequisites. Please distinguish this from sales without a consultation or person-to-person deals on social media.
QHow much does self-pay treatment cost per month?
It varies depending on the medical institution, dose, consultation fee, test fees, shipping and more. At Hiro Clinic, the total of the drug cost for 4 pens of 2.5 mg and standard shipping is ¥19,250 (tax incl.). Please check the latest prices and any additional costs before applying.
QCan I get Mounjaro prescribed without a consultation?
No. Even with online consultation, a doctor checks your health, medical history, other medications and more, and decides whether a prescription is appropriate and the dose. It may not be prescribed even if you request it.
QCan it be covered by insurance even for weight loss?
No. Using Mounjaro for weight-loss or cosmetic purposes is self-pay treatment. Whether it can be insurance-covered care as type 2 diabetes treatment is decided by a doctor based on the diagnosis and medical necessity.
QAre Mounjaro and Zepbound the same drug?
Both have the active ingredient tirzepatide, but they are separate brands and products with different approved indications and conditions of use in Japan. Mounjaro is approved for type 2 diabetes, and Zepbound for obesity disease meeting certain conditions.
Not sure? Talk to us
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)
Summary: understand what self-pay treatment means and what it costs, then talk to a doctor
Using Mounjaro for weight loss is off-label use, and public health insurance does not apply. With self-pay treatment, it is important to check not only the cost but also the doctor’s examination, the explanation of off-label use, how side effects are handled, and legitimate distribution and temperature control.
At Hiro Clinic, you can consult about Mounjaro online from your first visit. After checking your medical history, current medications and present health, a doctor decides whether a prescription is appropriate and the dose.
If it is urgent outside reception hours, please go to an emergency hospital. Call an ambulance if necessary.
References and primary sources
- PMDA: “Mounjaro Subcutaneous Injection Ateos: prescription drug information”
- PMDA: “Patient medication guide: Mounjaro Subcutaneous Injection Ateos”
- Posted by the PMDA: “Statement on the safe and appropriate use of obesity medications”
- Ministry of Health, Labour and Welfare: “Q&A on personal import of medicines and related products”
- National Tax Agency: “Medical expenses eligible for the medical expense deduction”
*Mounjaro’s approved indication in Japan is type 2 diabetes. Use for weight loss is off-label use and self-pay treatment. Zepbound, a treatment for obesity disease containing the same ingredient tirzepatide, has its own separate eligibility conditions. Whether treatment is appropriate is decided by a doctor after an examination.



